Journal article

Effects of carbon monoxide-releasing molecules on pulmonary vasoreactivity in isolated perfused lungs


Authors listPak, Oleg; Bakr, Adel G.; Gierhardt, Mareike; Albus, Julia; Strielkov, Ievgen; Kroschel, Florian; Hoeres, Timm; Hecker, Matthias; Ghofrani, Hossein A.; Seeger, Werner; Weissmann, Norbert; Sommer, Natascha

Publication year2016

Pages271-281

JournalJournal of Applied Physiology

Volume number120

Issue number2

ISSN8750-7587

eISSN1522-1601

Open access statusBronze

DOI Linkhttps://doi.org/10.1152/japplphysiol.00726.2015

PublisherAmerican Physiological Society


Abstract
In addition to its renowned poisonous effects, carbon monoxide (CO) is being recognized for its beneficial actions on inflammatory and vasoregulatory pathways, particularly when applied at low concentrations via CO-releasing molecules (CO-RMs). In the lung, CO gas and CO-RMs are suggested to decrease pulmonary vascular tone and hypoxic pulmonary vasoconstriction (HPV). However, the direct effect of CO-RMs on the pulmonary vasoreactivity in isolated lungs has not yet been investigated. We assessed the effect of CORM-2 and CORM-3 on the pulmonary vasculature during normoxia and acute hypoxia (1% oxygen for 10 min) in isolated ventilated and perfused mouse lungs. The effects were compared with those of inhaled CO gas (10%). The interaction of CORM-2 or CO with cytochrome P-450 (CYP) was measured simultaneously by tissue spectrophotometry. Inhaled CO decreased HPV and vasoconstriction induced by the thromboxane mimetic U-46619 but did not alter KCl-induced vasoconstriction. In contrast, concentrations of CORM-2 and CORM-3 used to elicit beneficial effects on the systemic circulation did not affect pulmonary vascular tone. High concentration of CO-RMs or long-term application induced a continuous increase in normoxic pressure. Inhaled CO showed spectral alterations correlating with the inhibition of CYP. In contrast, during application of CORM-2 spectrophotometric signs of interaction with CYP could not be detected. Application of CO-RMs in therapeutic doses in isolated lungs neither decreases pulmonary vascular tone and HPV nor does it induce spectral alterations that are characteristic of CO-inhibited CYP. High doses, however, may cause pulmonary vasoconstriction.



Citation Styles

Harvard Citation stylePak, O., Bakr, A., Gierhardt, M., Albus, J., Strielkov, I., Kroschel, F., et al. (2016) Effects of carbon monoxide-releasing molecules on pulmonary vasoreactivity in isolated perfused lungs, Journal of Applied Physiology, 120(2), pp. 271-281. https://doi.org/10.1152/japplphysiol.00726.2015

APA Citation stylePak, O., Bakr, A., Gierhardt, M., Albus, J., Strielkov, I., Kroschel, F., Hoeres, T., Hecker, M., Ghofrani, H., Seeger, W., Weissmann, N., & Sommer, N. (2016). Effects of carbon monoxide-releasing molecules on pulmonary vasoreactivity in isolated perfused lungs. Journal of Applied Physiology. 120(2), 271-281. https://doi.org/10.1152/japplphysiol.00726.2015



Keywords


carbon monoxide-releasing molecule-2carbon monoxide-releasing molecule-3HYPOXIC PULMONARY VASOCONSTRICTIONK-CA CHANNELSVASOCONSTRICTION

Last updated on 2025-10-06 at 10:35